June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Visual function outcome measures of a comparative trial of low vision enhancement head-mounted display systems (HMD)
Author Affiliations & Notes
  • Ashley Deemer
    Marshall B Ketchum University, Fullerton, California, United States
  • Rob Chun
    Institute for Vision Research, Manhattan Vision Associates, New York, New York, United States
  • Chris Bradley
    Lions Vision Research and Rehabilitation Center, Johns Hopkins Medicine, Baltimore, Maryland, United States
  • Kyoko Fujiwara
    Lions Vision Research and Rehabilitation Center, Johns Hopkins Medicine, Baltimore, Maryland, United States
  • James Deremeik
    Lions Vision Research and Rehabilitation Center, Johns Hopkins Medicine, Baltimore, Maryland, United States
  • Micaela R Gobeille
    Solinsky Eyecare, West Hartford, Connecticut, United States
    New England College of Optometry, Boston, Massachusetts, United States
  • Frank Werblin
    Division of Neurobiology, University of California Berkeley, Berkeley, California, United States
  • Robert W Massof
    Lions Vision Research and Rehabilitation Center, Johns Hopkins Medicine, Baltimore, Maryland, United States
  • Footnotes
    Commercial Relationships   Ashley Deemer None; Rob Chun None; Chris Bradley IrisVision Global, Code C (Consultant/Contractor); Kyoko Fujiwara None; James Deremeik None; Micaela Gobeille None; Frank Werblin Visionize LLC, Code E (Employment), Visionize LLC, Code F (Financial Support), Visionize LLC, Code I (Personal Financial Interest), Visionize LLC, Code O (Owner), Visionize LLC, Code P (Patent); Robert Massof IrisVision Global, Code C (Consultant/Contractor), IrisVision Global, Code P (Patent)
  • Footnotes
    Support  National Eye Institute EY026617 and EY028077
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 4232 – A0160. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ashley Deemer, Rob Chun, Chris Bradley, Kyoko Fujiwara, James Deremeik, Micaela R Gobeille, Frank Werblin, Robert W Massof; Visual function outcome measures of a comparative trial of low vision enhancement head-mounted display systems (HMD). Invest. Ophthalmol. Vis. Sci. 2022;63(7):4232 – A0160.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : A comparative clinical trial was conducted to evaluate the effectiveness of a virtual bioptic telescope in an HMD vision enhancement system possessing a wide field of view to currently employed specifications in HMD vision enhancement technology through patient reported outcome measures. As HMDs are being developed and implemented into clinical vision rehabilitation, it is important to evaluate the effectiveness of new features as it translates into the functional ability of visually impaired individuals.

Methods : Patients were randomized into two arms with the following HMD specifications: 1. a magnification bubble embedded in an unmagnified 70° field of view (bubble) and 2. full-screen magnification in a 45° field of view (legacy). Participants completed baseline testing then took the device home for a 2-4 week trial period. Participants were encouraged to use the device in their daily activities (excluding mobility). The Activity Inventory (AI) was administered before and after the home trial to measure the effect of system use on self-reported functional ability measures. Baseline and follow-up AI results were analyzed using Rasch analysis.

Results : A total of 88 (n=44 legacy, n=44 bubble) participants with BCVA of <20/60 in the better-seeing eye and at least 70° of peripheral visual field completed the study. There was no difference in age, BCVA, or baseline AI person measures between groups. In the legacy group, improvements were seen in reading (Cohen’s d=0.99, p <0.001) and inside-the-home tasks (d=0.44, p=0.04). In the bubble group, improvements were seen in reading (d=0.82, p <0.001) and visual information tasks (d=0.39, p=0.03). There was no improvement in visual motor function or mobility in either group. Between group effects did not reach statistical significance.

Conclusions : Based on the AI results, use of both the legacy and bubble HMD result in improvements in reading, visual information (i.e. seeing faces), and inside-the-home tasks with reading having the strongest effect size. The lack of improvement in mobility and visual motor function is expected and likely due to limited field of view and lack of binocular disparity. There were trends for legacy device users to report better outcomes with reading and in-home tasks and bubble users to report better outcomes with visual information tasks, but there was no significant difference between groups.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×